These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9021953)

  • 41. Letter: HLA antigens in haemochromatosis.
    Walters JM; Watt DW; Stevens FM; McCarthy CF
    Br Med J; 1975 Nov; 4(5995):520. PubMed ID: 1192157
    [No Abstract]   [Full Text] [Related]  

  • 42. [HLA system in symptomatic hepatic porphyria (author's transl)].
    Cervinka J; Kaláb M; Kordac V
    Cas Lek Cesk; 1981 Nov; 120(46):1408-11. PubMed ID: 7317925
    [No Abstract]   [Full Text] [Related]  

  • 43. [Histocompatibility antigens and primary hemochromatosis].
    de Miguel Mendieta E; Benito Urbina S; Balsa Criado A; Gijón Baños J
    Med Clin (Barc); 1987 Oct; 89(11):486-7. PubMed ID: 3682986
    [No Abstract]   [Full Text] [Related]  

  • 44. [Letter: Idiopathic hemochromatosis associated with HL-A 3 tissular antigen].
    Simon M; Pawlotsky Y; Bourel M; Fauchet R; Genetet B
    Nouv Presse Med; 1975 May; 4(19):1432. PubMed ID: 1153315
    [No Abstract]   [Full Text] [Related]  

  • 45. [The HLA system and liver disease].
    Jmelnitzky A; Morales V
    Acta Gastroenterol Latinoam; 1980; 10(2):161-5. PubMed ID: 7211136
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical studies on hemochromatosis].
    Lisboa PE; Correia JP; Baptista AM; Madeira F
    J Med (Oporto); 1965 Apr; 56(159):821-33. PubMed ID: 5214555
    [No Abstract]   [Full Text] [Related]  

  • 47. Hereditary hemochromatosis--importance of age and sex?
    Anand A; Anand N; Anand A
    West J Med; 1995 Aug; 163(2):182. PubMed ID: 7571580
    [No Abstract]   [Full Text] [Related]  

  • 48. Letter: HLA antigens in haemochromatosis.
    Shewan WG; Mouat SA; Allan TM
    Br Med J; 1976 Jan; 1(6004):281-2. PubMed ID: 1247819
    [No Abstract]   [Full Text] [Related]  

  • 49. The immunological system in hemochromatosis.
    de Sousa M; Porto G
    J Hepatol; 1998; 28 Suppl 1():1-7. PubMed ID: 9575441
    [No Abstract]   [Full Text] [Related]  

  • 50. Histocompatibility antigens and haemochromatosis in Ireland.
    McCarthy D; Fitzgerald GA; O'Connell LG; Waters JM; Watt DW; Stevens FM; McCarthy CF; Drury MI
    Ir J Med Sci; 1979; 148(5-6):168-72. PubMed ID: 511477
    [No Abstract]   [Full Text] [Related]  

  • 51. The CD4/CD8 ratio: message in a bottle?
    Chakravarti A
    Nat Med; 1995 Dec; 1(12):1240-1. PubMed ID: 7489396
    [No Abstract]   [Full Text] [Related]  

  • 52. [The age factor in hemochromatosis].
    RECHENBERGER J
    Z Alternsforsch; 1955 Nov; 9(3):238-46. PubMed ID: 13300211
    [No Abstract]   [Full Text] [Related]  

  • 53. [Idiopathic hemochromatosis. Report of a case in a woman of childbearing age].
    Cabades F; Gras MD; Olaso V; Berenguer J
    Rev Esp Enferm Apar Dig; 1978 Feb; 52(3):373-82. PubMed ID: 635296
    [No Abstract]   [Full Text] [Related]  

  • 54. Correction: A Population-Based Study of the Clinical Expression of the Hemochromatosis Gene.
    N Engl J Med; 1999 Nov; 341(22):1708. PubMed ID: 10572163
    [No Abstract]   [Full Text] [Related]  

  • 55. HFE Related Hemochromatosis: Uncovering the Inextricable Link between Iron Homeostasis and the Immunological System.
    Porto G; Cruz E; Teles MJ; de Sousa M
    Pharmaceuticals (Basel); 2019 Aug; 12(3):. PubMed ID: 31443397
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Iron in the Tumor Microenvironment-Connecting the Dots.
    Pfeifhofer-Obermair C; Tymoszuk P; Petzer V; Weiss G; Nairz M
    Front Oncol; 2018; 8():549. PubMed ID: 30534534
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lymphocyte gene expression signatures from patients and mouse models of hereditary hemochromatosis reveal a function of HFE as a negative regulator of CD8+ T-lymphocyte activation and differentiation in vivo.
    Costa M; Cruz E; Oliveira S; Benes V; Ivacevic T; Silva MJ; Vieira I; Dias F; Fonseca S; Gonçalves M; Lima M; Leitão C; Muckenthaler MU; Pinto J; Porto G
    PLoS One; 2015; 10(4):e0124246. PubMed ID: 25880808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physiological implications of NTBI uptake by T lymphocytes.
    Pinto JP; Arezes J; Dias V; Oliveira S; Vieira I; Costa M; Vos M; Carlsson A; Rikers Y; Rangel M; Porto G
    Front Pharmacol; 2014; 5():24. PubMed ID: 24616700
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of highly conserved major histocompatibility complex (MHC) extended haplotypes on iron and low CD8+ T lymphocyte phenotypes in HFE C282Y homozygous hemochromatosis patients from three geographically distant areas.
    Costa M; Cruz E; Barton JC; Thorstensen K; Morais S; da Silva BM; Pinto JP; Vieira CP; Vieira J; Acton RT; Porto G
    PLoS One; 2013; 8(11):e79990. PubMed ID: 24282517
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ER Stress and Iron Homeostasis: A New Frontier for the UPR.
    Oliveira SJ; de Sousa M; Pinto JP
    Biochem Res Int; 2011; 2011():896474. PubMed ID: 21197476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.